Patents by Inventor Hillary A. Keenan

Hillary A. Keenan has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • RETINOL-BINDING PROTEIN 3 (RBP3) AS A PROTECTIVE FACTOR IN NON-DIABETIC RETINAL DEGENERATION
    Publication number: 20210000855
    Abstract: Methods for increasing retinal thickness in a non-diabetic mammal, comprising administering to the mammal one or both of: (i) a composition comprising RBP3 polypeptide, and/or (ii) a composition comprising a nucleic acid encoding an RBP3 polypeptide.
    Type: Application
    Filed: May 4, 2020
    Publication date: January 7, 2021
    Inventors: George Liang King, Hillary A. Keenan
  • RETINOL-BINDING PROTEIN 3 (RBP3) AS A PROTECTIVE FACTOR IN NON-DIABETIC RETINAL DEGENERATION
    Publication number: 20180140626
    Abstract: Methods for increasing retinal thickness in a non-diabetic mammal, comprising administering to the mammal one or both of: (i) a composition comprising RBP3 polypeptide, and/or (ii) a composition comprising a nucleic acid encoding an RBP3 polypeptide.
    Type: Application
    Filed: May 16, 2016
    Publication date: May 24, 2018
    Inventors: George Liang KING, Hillary A. KEENAN
  • Predicting and treating diabetic complications
    Patent number: 9921221
    Abstract: Compositions and methods for diagnosing, predicting risk of and/or treating diabetic nephropathy (DN).
    Type: Grant
    Filed: July 26, 2013
    Date of Patent: March 20, 2018
    Assignee: Joslin Diabetes Center, Inc.
    Inventors: George L. King, Hillary A. Keenan
  • Methods to Accelerate Wound Healing in Diabetic Subjects
    Publication number: 20180066327
    Abstract: Methods of accelerating wound healing in diabetic subjects using autologous cell grafts treated to specifically inhibit Protein Kinase C delta (PKC6), as well as cells and compositions for use in these methods. Provided herein are methods for preparing cells for application to a wound in a diabetic subject. The methods include incubating the cells in the presence of an effective amount of a PKC6 inhibitor.
    Type: Application
    Filed: March 14, 2016
    Publication date: March 8, 2018
    Inventors: George Liang King, Mogher Khamaisi, Hillary A. Keenan
  • Predicting and treating diabetic complications
    Patent number: 9283262
    Abstract: Compositions and methods for diagnosing, predicting risk of, and/or treating diabetic retinopathy and/or diabetic nephropathy.
    Type: Grant
    Filed: December 6, 2011
    Date of Patent: March 15, 2016
    Assignee: Joslin Diabetes Center, Inc.
    Inventors: George L. King, Hillary A. Keenan
  • PREDICTING AND TREATING DIABETIC COMPLICATIONS
    Publication number: 20150204874
    Abstract: Compositions and methods for diagnosing, predicting risk of and/or treating diabetic nephropathy (DN).
    Type: Application
    Filed: July 26, 2013
    Publication date: July 23, 2015
    Applicant: Joslin Diabetes Center, Inc.
    Inventors: George L. King, Hillary A. Keenan
  • PREDICTING AND TREATING DIABETIC COMPLICATIONS
    Publication number: 20140187498
    Abstract: Compositions and methods for diagnosing, predicting risk of, and/or treating diabetic retinopathy and/or diabetic nephropathy.
    Type: Application
    Filed: December 6, 2011
    Publication date: July 3, 2014
    Inventors: George L. King, Hillary A. Keenan